Details for Patent: 10,683,499

Which drugs does patent 10,683,499 protect, and when does it expire?

Patent 10,683,499 protects WAINUA (AUTOINJECTOR) and is included in one NDA.

This patent has two hundred and thirty-four patent family members in thirty-five countries.

Summary for Patent: 10,683,499

Patent landscape, scope, and claims:

Title:	Compositions and methods for modulating TTR expression
Abstract:	Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.
Inventor(s):	Prakash Thazha P., Seth Punit P., Swayze Eric E.
Assignee:	Ionis Pharmaceuticals, Inc.
Application Number:	US15687306
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,683,499

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Astrazeneca Ab	WAINUA (AUTOINJECTOR)	eplontersen sodium	SOLUTION;SUBCUTANEOUS	217388-001	Dec 21, 2023		RX	Yes	Yes	10,683,499		Y	Y		TREATMENT OF POLYNEUROPATHY OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS

International Family Members for US Patent 10,683,499

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2014259750
Australia	2014259755
Australia	2014259756
Australia	2014259757
Australia	2014259759